JPMorgan lowered the firm’s price target on Varonis (VRNS) to $38 from $50 and keeps an Overweight rating on the shares. The firm views the company’s Q4 results as “better than feared” with 32% year-over-year net new annual recurring revenue growth excluding conversions. It remains constructive on the long-term growth potential of Varonis’ software-as-a-service business. The fiscal 2026 outlook is a “good starting point,” the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis price target lowered to $50 from $60 at Jefferies
- Varonis price target lowered to $28 from $37 at Citi
- Varonis price target lowered to $40 from $57 at TD Cowen
- Varonis price target lowered to $38 from $45 at Barclays
- Varonis: SaaS Transition Nearing Maturity Drives Long-Term Growth and Attractive Risk-Reward, Justifying Buy Rating